Takeda Pharmaceutical Company Ownership 2024 | Who Owns Takeda Pharmaceutical Company Now?


OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

0.93%

Insider Ownership

0.01%

Retail Ownership

99.06%

Institutional Holders

155.00

Takeda Pharmaceutical Company Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CAPITAL RESEARCH GLOBAL INVESTORS0.84%0.04%13,126,6084,6780.04%169,858,308Jun 30, 2024
MONDRIAN INVESTMENT PARTNERS LTD0.49%1.67%7,738,748-4,341,214-35.94%108,342,472Jun 30, 2024
MORGAN STANLEY0.32%0.01%4,986,952-8,671-0.17%64,531,174Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.28%0.03%4,346,1512,023,70787.14%56,239,194Jun 30, 2024
GOLDMAN SACHS GROUP INC0.24%0.01%3,717,457-491,974-11.69%48,103,897Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.19%0.06%2,954,800-163,400-5.24%38,235,112Jun 30, 2024
FMR LLC0.17%0.00%2,622,86648,6261.89%33,939,879Jun 30, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.15%0.03%2,315,515950,58869.64%29,963,000Jun 30, 2024
VAN ECK ASSOCIATES CORP0.13%0.04%2,040,829356,06921.13%26,408,000Jun 30, 2024
MANAGED ASSET PORTFOLIOS, LLC0.10%3.10%1,613,472-70,204-4.17%20,878,326Jun 30, 2024
NORTHERN TRUST CORP0.10%0.00%1,590,525-275,628-14.77%20,581,393,000Jun 30, 2024
ENVESTNET ASSET MANAGEMENT INC0.09%0.01%1,483,493-45,894-3.00%19,196,402Jun 30, 2024
BLACKROCK INC.0.09%0.00%1,436,352-558,236-27.99%18,586,401Jun 30, 2024
CAUSEWAY CAPITAL MANAGEMENT LLC0.09%0.48%1,354,164-90,744-6.28%17,522,888Jun 30, 2024
MACQUARIE GROUP LTD0.07%0.02%1,045,871-1,200,878-53.45%13,533,193Jun 30, 2024
WELLS FARGO & COMPANY/MN0.06%0.00%871,66720,7222.44%11,279,373Jun 30, 2024
BANK OF AMERICA CORP /DE/0.06%0.00%867,059-616,950-41.57%11,219,745Jun 30, 2024
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC0.04%0.02%585,843-14,069-2.35%7,580,817Jun 30, 2024
COWEN AND COMPANY, LLC0.03%0.19%530,600530,600100.00%6,865,964Jun 30, 2024
NATIXIS ADVISORS, L.P.0.03%0.01%468,111-214,178-31.39%6,057,000Jun 30, 2024

Takeda Pharmaceutical Company's largest institutional shareholder is CAPITAL RESEARCH GLOBAL INVESTORS, holding 0.84% of the company's total share outstanding, currently valued at $169.86M. The top 10 institutional shareholders own together 2.90% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MANAGED ASSET PORTFOLIOS, LLC0.10%3.10%1,613,472-70,204-4.17%20,878,326Jun 30, 2024
XY CAPITAL LTD0.02%2.81%344,049121,77154.78%4,451,994Jun 30, 2024
GROUPAMA ASSET MANAGMENT0.00%2.77%53,50023,50078.33%204,391,314Jun 30, 2024
CLEAN YIELD GROUP0.03%2.15%445,140-36,312-7.54%5,760,112Jun 30, 2024
MONDRIAN INVESTMENT PARTNERS LTD0.49%1.67%7,738,748-4,341,214-35.94%108,342,472Jun 30, 2024
LEGACY WEALTH ASSET MANAGEMENT, LLC0.01%0.60%164,4146,8684.36%2,127,517Jun 30, 2024
CAUSEWAY CAPITAL MANAGEMENT LLC0.09%0.48%1,354,164-90,744-6.28%17,522,888Jun 30, 2024
GOLD INVESTMENT MANAGEMENT LTD.0.00%0.39%71,7761,4532.07%928,781Jun 30, 2024
SUMMIT GLOBAL INVESTMENTS0.01%0.20%223,415-34,378-13.34%2,891,000Jun 30, 2024
COWEN AND COMPANY, LLC0.03%0.19%530,600530,600100.00%6,865,964Jun 30, 2024
NAVITER WEALTH, LLC0.01%0.15%79,1569,69013.95%1,024,279Jun 30, 2024
INVESTORS RESEARCH CORP0.00%0.14%45,794--592,574Jun 30, 2024
ETHIC INC.0.03%0.14%455,87416,0553.65%5,899,009Jun 30, 2024
CUTTER & CO BROKERAGE, INC.0.00%0.13%41,9741,3473.32%543,149Jun 30, 2024
KELLEHER FINANCIAL ADVISORS0.00%0.12%23,063--298,439Jun 30, 2024
GALLACHER CAPITAL MANAGEMENT LLC0.00%0.12%17,3651,1367.00%224,707Jun 30, 2024
BRIDGEFRONT CAPITAL, LLC0.00%0.12%21,3731,0955.40%276,567Jun 30, 2024
SCHECHTER INVESTMENT ADVISORS, LLC0.01%0.11%115,290-12,013-9.44%1,491,852Jun 30, 2024
COASTAL BRIDGE ADVISORS, LLC0.00%0.11%34,852350.10%450,985Jun 30, 2024
BLEAKLEY FINANCIAL GROUP, LLC0.02%0.11%299,98411,4493.97%3,881,791Jun 30, 2024

The largest Takeda Pharmaceutical Company shareholder by % of total assets is MANAGED ASSET PORTFOLIOS, LLC. The company owns 1.61M shares of Takeda Pharmaceutical Company (TAK), representing 3.10% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC0.28%0.03%4,346,1512,023,70787.14%56,239,194Jun 30, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.15%0.03%2,315,515950,58869.64%29,963,000Jun 30, 2024
COWEN AND COMPANY, LLC0.03%0.19%530,600530,600100.00%6,865,964Jun 30, 2024
VAN ECK ASSOCIATES CORP0.13%0.04%2,040,829356,06921.13%26,408,000Jun 30, 2024
MANNING & NAPIER ADVISORS LLC0.02%0.05%316,690316,690100.00%4,097,968Jun 30, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.02%0.02%350,000175,000100.00%4,529,000Jun 30, 2024
PEAK6 INVESTMENTS LLC0.01%0.01%227,500134,400144.36%2,943,850Jun 30, 2024
OLD MISSION CAPITAL LLC0.01%0.05%223,058124,087125.38%2,886,370Jun 30, 2024
XY CAPITAL LTD0.02%2.81%344,049121,77154.78%4,451,994Jun 30, 2024
JANUS HENDERSON GROUP PLC0.02%0.00%309,318111,89456.68%4,002,575Jun 30, 2024
QUANTINNO CAPITAL MANAGEMENT LP0.02%0.08%351,455104,38642.25%4,547,837Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.01%0.01%89,40089,400100.00%1,156,836Jun 30, 2024
PEAK6 INVESTMENTS LLC0.01%0.00%79,50765,252457.75%1,028,821Jun 30, 2024
COLONY GROUP, LLC0.01%0.01%127,80664,982103.44%1,683,000Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC0.01%0.00%90,01354,539153.74%1,164,768Jun 30, 2024
FMR LLC0.17%0.00%2,622,86648,6261.89%33,939,879Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.01%0.00%159,53745,77040.23%2,064,409Jun 30, 2024
VANGUARD GROUP INC0.01%-102,27745,39679.81%1,323,465Jun 30, 2024
CAPSTONE INVESTMENT ADVISORS, LLC0.00%0.00%40,16240,162100.00%519,696Jun 30, 2024
EXCHANGE TRADED CONCEPTS, LLC0.00%0.01%35,71535,715100.00%462,152Jun 30, 2024

As of Jun 30 2024, Takeda Pharmaceutical Company's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 2.02M stocks of TAK, valued at $56.24M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MONDRIAN INVESTMENT PARTNERS LTD0.49%1.67%7,738,748-4,341,214-35.94%108,342,472Jun 30, 2024
MACQUARIE GROUP LTD0.07%0.02%1,045,871-1,200,878-53.45%13,533,193Jun 30, 2024
BANK OF AMERICA CORP /DE/0.06%0.00%867,059-616,950-41.57%11,219,745Jun 30, 2024
BLACKROCK INC.0.09%0.00%1,436,352-558,236-27.99%18,586,401Jun 30, 2024
GOLDMAN SACHS GROUP INC0.24%0.01%3,717,457-491,974-11.69%48,103,897Jun 30, 2024
D. E. SHAW & CO., INC.----354,299-100.00%-Jun 30, 2024
GTS SECURITIES LLC0.00%0.00%38,294-330,165-89.61%495,524Jun 30, 2024
NORTHERN TRUST CORP0.10%0.00%1,590,525-275,628-14.77%20,581,393,000Jun 30, 2024
LMR PARTNERS LLP----271,143-100.00%-Jun 30, 2024
NATIXIS ADVISORS, L.P.0.03%0.01%468,111-214,178-31.39%6,057,000Jun 30, 2024
FEDERATED HERMES, INC.0.02%0.01%380,873-209,700-35.51%4,928,497,000Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.----206,100-100.00%-Jun 30, 2024
FRANKLIN RESOURCES INC----185,572-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.19%0.06%2,954,800-163,400-5.24%38,235,112Jun 30, 2024
PINPOINT ASSET MANAGEMENT LTD----147,600-100.00%-Jun 30, 2024
LEO WEALTH, LLC----124,449-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----114,209-100.00%-Jun 30, 2024
ROCKEFELLER CAPITAL MANAGEMENT L.P.----104,543-100.00%-Jun 30, 2024
CAUSEWAY CAPITAL MANAGEMENT LLC0.09%0.48%1,354,164-90,744-6.28%17,522,888Jun 30, 2024
STIFEL FINANCIAL CORP0.01%0.00%216,072-78,143-26.56%2,795,984Jun 30, 2024

As of Jun 30 2024, Takeda Pharmaceutical Company's biggest institutional seller is MONDRIAN INVESTMENT PARTNERS LTD. The company sold -4.34M shares of TAK, valued at $108.34M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
COWEN AND COMPANY, LLC0.03%0.19%530,600530,600100.00%6,865,964Jun 30, 2024
MANNING & NAPIER ADVISORS LLC0.02%0.05%316,690316,690100.00%4,097,968Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.01%0.01%89,40089,400100.00%1,156,836Jun 30, 2024
CAPSTONE INVESTMENT ADVISORS, LLC0.00%0.00%40,16240,162100.00%519,696Jun 30, 2024
EXCHANGE TRADED CONCEPTS, LLC0.00%0.01%35,71535,715100.00%462,152Jun 30, 2024
RITHOLTZ WEALTH MANAGEMENT0.00%0.01%24,31924,319100.00%314,688Jun 30, 2024
CHOREO, LLC0.00%0.00%22,44222,442100.00%291,570Jun 30, 2024
ATRIA INVESTMENTS, INC0.00%0.00%21,92321,923100.00%283,684Jun 30, 2024
CABLE HILL PARTNERS, LLC0.00%0.03%17,72717,727100.00%234,721Jun 30, 2024
BUCKINGHAM STRATEGIC WEALTH, LLC0.00%0.00%11,61311,613100.00%150,272Jun 30, 2024
IEQ CAPITAL, LLC0.00%0.00%10,92910,929100.00%141,415Jun 30, 2024
RIDGEWOOD INVESTMENTS LLC0.00%0.04%6,9006,900100.00%89,284Jun 30, 2024
COMPAGNIE LOMBARD ODIER SCMA0.00%0.00%1,8471,847100.00%23,900Jun 30, 2024
STRENGTHENING FAMILIES & COMMUNITIES, LLC-0.00%753753100.00%10,000Jun 30, 2024
VENTURI WEALTH MANAGEMENT, LLC-0.00%671671100.00%8,683Jun 30, 2024
TORTOISE INVESTMENT MANAGEMENT, LLC-0.00%654654100.00%8,463Jun 30, 2024
CREDIT AGRICOLE S A--574574100.00%7,428Jun 30, 2024
OPAL WEALTH ADVISORS, LLC-0.00%455455100.00%5,888Jun 30, 2024
CAMELOT PORTFOLIOS, LLC-0.00%387387100.00%5,008Jun 30, 2024
CREATIVE FINANCIAL DESIGNS INC /ADV-0.00%265265100.00%3,429Jun 30, 2024
LYNX INVESTMENT ADVISORY-0.00%144144100.00%1,863,000Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC-0.00%9595100.00%1,229Jun 30, 2024
MENDOTA FINANCIAL GROUP, LLC-0.00%3030100.00%389Jun 30, 2024

Takeda Pharmaceutical Company's largest new institutional shareholder by number of shares is COWEN AND COMPANY, LLC, purchased 530.60K shares, valued at $6.87M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
D. E. SHAW & CO., INC.----354,299-100.00%-Jun 30, 2024
LMR PARTNERS LLP----271,143-100.00%-Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.----206,100-100.00%-Jun 30, 2024
FRANKLIN RESOURCES INC----185,572-100.00%-Jun 30, 2024
PINPOINT ASSET MANAGEMENT LTD----147,600-100.00%-Jun 30, 2024
LEO WEALTH, LLC----124,449-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----114,209-100.00%-Jun 30, 2024
ROCKEFELLER CAPITAL MANAGEMENT L.P.----104,543-100.00%-Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC----74,190-100.00%-Jun 30, 2024
CAPITAL FUND MANAGEMENT S.A.----69,026-100.00%-Jun 30, 2024
SQUAREPOINT OPS LLC----66,760-100.00%-Jun 30, 2024
FNY INVESTMENT ADVISERS, LLC----61,956-100.00%-Jun 30, 2024
TEAM HEWINS, LLC----48,967-100.00%-Jun 30, 2024
CLAL INSURANCE ENTERPRISES HOLDINGS LTD----45,000-100.00%-Jun 30, 2024
XTX TOPCO LTD----42,116-100.00%-Jun 30, 2024
EMPLOYEES RETIREMENT SYSTEM OF TEXAS----39,577-100.00%-Jun 30, 2024
COVENANT PARTNERS, LLC----28,340-100.00%-Jun 30, 2024
CENTERPOINT ADVISORS, LLC----27,000-100.00%-Jun 30, 2024
ENGINEERS GATE MANAGER LP----26,184-100.00%-Jun 30, 2024
CALLAN CAPITAL, LLC----25,461-100.00%-Jun 30, 2024
WALLEYE TRADING LLC----25,400-100.00%-Jun 30, 2024
LESTER MURRAY ANTMAN DBA SIMPLYRICH----25,245-100.00%-Jun 30, 2024
HRT FINANCIAL LP----23,195-100.00%-Jun 30, 2024
NOMURA HOLDINGS INC----16,800-100.00%-Jun 30, 2024
SG AMERICAS SECURITIES, LLC----16,099-100.00%-Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.----15,354-100.00%-Jun 30, 2024
EVERGREEN CAPITAL MANAGEMENT LLC----13,774-100.00%-Jun 30, 2024
FLOW TRADERS U.S. LLC----12,245-100.00%-Jun 30, 2024
PERIGON WEALTH MANAGEMENT, LLC----11,961-100.00%-Jun 30, 2024
KESTRA ADVISORY SERVICES, LLC----11,918-100.00%-Jun 30, 2024
SAGE RHINO CAPITAL LLC----11,787-100.00%-Jun 30, 2024
SVB WEALTH LLC----11,438-100.00%-Jun 30, 2024
AXXCESS WEALTH MANAGEMENT, LLC----10,961-100.00%-Jun 30, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----10,930-100.00%-Jun 30, 2024
PDS PLANNING, INC----10,553-100.00%-Jun 30, 2024
ICON WEALTH ADVISORS, LLC----7,688-100.00%-Jun 30, 2024
NEMES RUSH GROUP LLC----3,003-100.00%-Jun 30, 2024
HANSON & DOREMUS INVESTMENT MANAGEMENT----1,000-100.00%-Jun 30, 2024
JTC EMPLOYER SOLUTIONS TRUSTEE LTD----971-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----711-100.00%-Jun 30, 2024
HHM WEALTH ADVISORS, LLC----456-100.00%-Jun 30, 2024
TWIN TREE MANAGEMENT, LP----388-100.00%-Jun 30, 2024
REDMONT WEALTH ADVISORS LLC----266-100.00%-Jun 30, 2024
FORTITUDE FAMILY OFFICE, LLC----243-100.00%-Jun 30, 2024
VALUED WEALTH ADVISORS LLC----231-100.00%-Jun 30, 2024
YHB INVESTMENT ADVISORS, INC.----221-100.00%-Jun 30, 2024
FIRST MANHATTAN CO. LLC.----94-100.00%-Jun 30, 2024
SANCTUARY WEALTH MANAGEMENT, L.L.C.----84-100.00%-Jun 30, 2024
CORECAP ADVISORS, LLC----75-100.00%-Jun 30, 2024
JANICZEK WEALTH MANAGEMENT, LLC----72-100.00%-Jun 30, 2024
HOUSEHOLDER GROUP ESTATE & RETIREMENT SPECIALIST, LLC----70-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----68-100.00%-Jun 30, 2024
BALDWIN BROTHERS LLC/MA----35-100.00%-Jun 30, 2024
HARBOR INVESTMENT ADVISORY, LLC----24-100.00%-Jun 30, 2024
SUGARLOAF WEALTH MANAGEMENT, LLC----15-100.00%-Jun 30, 2024

Takeda Pharmaceutical Company's largest sold out institutional shareholder by shares sold is D. E. SHAW & CO., INC., sold -0.35M shares, valued at -, as of undefined.

Takeda Pharmaceutical Company Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
AMERICAN MUTUAL FUND1.39%12,977,537-670,703-4.91%Jan 31, 2024
Invesco Exchange Fund1.37%6,080--Mar 31, 2024
INVESCO BLDRS INDEX FUNDS TRUST1.00%56,907--Dec 31, 2022
Gabelli ESG Fund, Inc.0.78%6,350--Dec 29, 2023
Gabelli Healthcare & WellnessRx Trust0.75%90,415--Dec 29, 2023
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.58%1,342,127--Mar 31, 2024
GABELLI ASSET FUND0.18%65,442--Dec 29, 2023
NUVEEN INVESTMENT TRUST0.17%95,366--Mar 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND0.14%1,386,314--Mar 31, 2024
VIRTUS VARIABLE INSURANCE TRUST0.09%142,398-3,023-2.08%Mar 28, 2024
Tekla World Healthcare Fund0.09%105,073--Mar 31, 2024
AMERICAN CENTURY VARIABLE PORTFOLIOS INC0.08%201,504--Mar 31, 2024
GABELLI DIVIDEND & INCOME TRUST0.07%125,850--Dec 29, 2023
FIRST TRUST EXCHANGE-TRADED FUND II0.03%233,119--Mar 31, 2024
VIRTUS EQUITY TRUST0.03%212,656-6,994-3.18%Mar 28, 2024
World Funds Trust0.02%10,440--Jan 31, 2024
DOMINI INVESTMENT TRUST0.02%103,200--Jan 31, 2024
TAX-MANAGED GROWTH PORTFOLIO0.01%5,036--Mar 31, 2024
T. Rowe Price Spectrum Funds II, Inc.0.01%158,792--Feb 29, 2024
Fidelity Commonwealth Trust II0.01%69,120--Aug 31, 2023
T. Rowe Price Balanced Fund, Inc.0.01%131,895--Mar 31, 2024
GLENMEDE FUND INC0.01%46,877--Jan 31, 2024
T. Rowe Price Global Allocation Fund, Inc.0.00%7,410--Jan 31, 2024
PRAXIS MUTUAL FUNDS0.00%41,354--Dec 31, 2023
LEUTHOLD FUNDS INC0.00%6,558--Mar 31, 2024
RBB FUND, INC.0.00%314,4729280.30%Feb 29, 2024
AMERICAN PENSION INVESTORS TRUST0.00%16,000--Jan 31, 2024
T. Rowe Price Equity Series, Inc.0.00%3,491--Mar 31, 2024
AMERICAN CENTURY ETF TRUST0.00%234,43417,0217.83%Feb 29, 2024
Advisors Preferred Trust0.00%13,986--Mar 31, 2024
Listed Funds Trust0.00%9,835--Mar 31, 2024
DEUTSCHE DWS SECURITIES TRUST0.00%69,178--Jan 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%115,400--Feb 29, 2024
PROFESSIONALLY MANAGED PORTFOLIOS0.00%75,000--Feb 29, 2024
ETF Managers Trust0.00%6,176-1,115-15.29%Dec 31, 2023
DFA INVESTMENT TRUST CO0.00%114,440--Jan 31, 2024
SEASONS SERIES TRUST0.00%17,236--Mar 31, 2024
TRUST FOR PROFESSIONAL MANAGERS0.00%212,405-116,151-35.35%Feb 29, 2024
MANNING & NAPIER FUND, INC.0.00%30,190--Jan 31, 2024
Pacer Funds Trust0.00%29,546-895,093-96.80%Jan 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%36,944--Jan 31, 2024
VANGUARD TAX-MANAGED FUNDS0.00%83,354--Mar 31, 2024
Ark ETF Trust0.00%3,090--Jan 31, 2024
JOHNSON MUTUAL FUNDS TRUST0.00%9,340--Mar 31, 2024
Amplify ETF Trust0.00%6,2496,249-Mar 31, 2024
Fidelity Rutland Square Trust II0.00%216,511--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%50,409--Mar 31, 2024
Advisors' Inner Circle Fund III0.00%12,831--Jan 31, 2024
ADVANCED SERIES TRUST0.00%251,723--Mar 28, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%67,708--Mar 31, 2024
T. Rowe Price International Funds, Inc.0.00%2,742,274--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%56,435--Dec 31, 2023
MUTUAL FUND SERIES TRUST0.00%169,000--Mar 31, 2024
SHELTON FUNDS0.00%65--Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%5,001--Jan 31, 2024
VanEck ETF Trust0.00%1,643,429243,80517.42%Mar 31, 2024
MORGAN STANLEY VARIABLE INSURANCE FUND INC.0.00%2,312--Mar 31, 2024
Dimensional ETF Trust0.00%12,264--Jan 31, 2024
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS0.00%56,881--Jan 31, 2024
JANUS INVESTMENT FUND0.00%7,594--Dec 31, 2023
AB GLOBAL RISK ALLOCATION FUND, INC.0.00%1,184--Feb 29, 2024
Investment Managers Series Trust0.00%33,694--Mar 31, 2024
COLUMBIA FUNDS SERIES TRUST I0.00%35,791--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%7,399-2,051-21.71%Jan 31, 2024
SEI INSTITUTIONAL INTERNATIONAL TRUST0.00%83,793--Dec 31, 2023
T. Rowe Price Global Funds, Inc.0.00%3,637--Mar 31, 2024
Series Portfolios Trust0.00%24--Jan 31, 2024
FRANKLIN TEMPLETON VARIABLE INSURANCE PRODUCTS TRUST0.00%29,604--Mar 31, 2024
JPMorgan Trust I0.00%1,779--Jan 31, 2024
PACIFIC SELECT FUND0.00%5,060--Mar 31, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%3,449--Dec 31, 2023

Takeda Pharmaceutical Company's largest mutual fund holder by % of total assets is "AMERICAN MUTUAL FUND", owning 12.98M shares, compromising 1.39% of its total assets.

Takeda Pharmaceutical Company Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24155-51.26%
31 Mar, 243182.91%
31 Dec, 23309-1.59%
30 Sep, 23314-0.32%
30 Jun, 233154.30%
31 Mar, 233026.71%
31 Dec, 222832.91%
30 Sep, 222750.36%
30 Jun, 22274-3.86%
31 Mar, 22285-5.32%
31 Dec, 213010.33%
30 Sep, 21300-3.54%
30 Jun, 21311-6.61%
31 Mar, 213331.22%
31 Dec, 203292.17%
30 Sep, 20322-0.31%
30 Jun, 203230.94%
31 Mar, 20320-8.83%
31 Dec, 193515.72%
30 Sep, 19332-9.29%
30 Jun, 19366-10.51%
31 Mar, 19409321.65%
31 Dec, 1897506.25%
30 Sep, 181614.29%
30 Jun, 181440.00%
31 Mar, 1810-
31 Dec, 171025.00%
30 Sep, 178-
30 Jun, 178-
31 Mar, 17814.29%
31 Dec, 16716.67%
30 Sep, 166-14.29%
30 Jun, 167-22.22%
31 Mar, 169-
31 Dec, 15912.50%
30 Sep, 15814.29%
30 Jun, 157-
31 Mar, 157-
31 Dec, 147-
30 Sep, 14716.67%
30 Jun, 146-25.00%
31 Mar, 148-33.33%
31 Dec, 131233.33%
30 Sep, 139-10.00%
30 Jun, 1310100.00%
31 Mar, 13566.67%
31 Dec, 12350.00%
30 Sep, 122-33.33%
30 Jun, 123-
31 Mar, 12350.00%
31 Dec, 112100.00%
30 Sep, 111-
30 Jun, 111-75.00%
31 Mar, 114-20.00%
31 Dec, 10566.67%
30 Sep, 10350.00%
30 Jun, 102100.00%
31 Mar, 101-

As of 30 Jun 24, 155 institutions are holding Takeda Pharmaceutical Company's shares, representing a decrease of -51.26% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2414,535,864-81.43%
31 Mar, 2478,260,425-6.36%
31 Dec, 2383,572,6743.95%
30 Sep, 2380,395,384-4.29%
30 Jun, 2383,995,697-3.50%
31 Mar, 2387,045,07127.85%
31 Dec, 2268,081,5346.74%
30 Sep, 2263,785,02412.04%
30 Jun, 2256,930,7811.12%
31 Mar, 2256,300,469-25.98%
31 Dec, 2176,059,746-17.15%
30 Sep, 2191,800,960-2.97%
30 Jun, 2194,615,209-12.09%
31 Mar, 21107,631,855-0.90%
31 Dec, 20108,612,6081.13%
30 Sep, 20107,397,222-3.71%
30 Jun, 20111,537,997-3.63%
31 Mar, 20115,738,587-11.29%
31 Dec, 19130,470,580-8.96%
30 Sep, 19143,318,853-1.14%
30 Jun, 19144,969,670-18.86%
31 Mar, 19178,671,694230.85%
31 Dec, 1854,003,8321751.04%
30 Sep, 182,917,49217.24%
30 Jun, 182,488,58431.62%
31 Mar, 181,890,67713.95%
31 Dec, 171,659,16619.88%
30 Sep, 171,383,97933.08%
30 Jun, 171,039,95814.32%
31 Mar, 17909,69251.86%
31 Dec, 16599,0322.09%
30 Sep, 16586,79730.48%
30 Jun, 16449,729-37.77%
31 Mar, 16722,74629.70%
31 Dec, 15557,239141.61%
30 Sep, 15230,635-58.46%
30 Jun, 15555,2695.08%
31 Mar, 15528,42016.19%
31 Dec, 14454,782-0.89%
30 Sep, 14458,8625.62%
30 Jun, 14434,429-40.07%
31 Mar, 14724,954-9.12%
31 Dec, 13797,6752.49%
30 Sep, 13778,3085.21%
30 Jun, 13739,771119.55%
31 Mar, 13336,94770.40%
31 Dec, 12197,73883.39%
30 Sep, 12107,822-59.04%
30 Jun, 12263,23412.89%
31 Mar, 12233,1771.17%
31 Dec, 11230,471490.50%
30 Sep, 1139,03066.13%
30 Jun, 1123,493-81.41%
31 Mar, 11126,36045.51%
31 Dec, 1086,842-92.27%
30 Sep, 101,123,645-4.17%
30 Jun, 101,172,6001395852.38%
31 Mar, 1084-

Takeda Pharmaceutical Company (TAK) has 14.54M shares outstanding as of 30 Jun 24, down -81.43% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 240.93%3.72%
31 Mar, 244.99%17.58%
31 Dec, 235.33%79.65%
30 Sep, 232.59%35.43%
30 Jun, 232.70%34.47%
31 Mar, 232.80%58.38%
31 Dec, 222.19%51.88%
30 Sep, 222.05%62.12%
30 Jun, 221.82%56.22%
31 Mar, 221.80%30.46%
31 Dec, 212.43%28.49%
30 Sep, 212.92%31.97%
30 Jun, 213.02%25.57%
31 Mar, 213.44%28.49%
31 Dec, 203.47%29.44%
30 Sep, 203.44%26.84%
30 Jun, 203.58%25.96%
31 Mar, 203.71%21.17%
31 Dec, 194.19%19.80%
30 Sep, 194.60%21.18%
30 Jun, 194.66%14.13%
31 Mar, 195.74%48.47%
31 Dec, 183.44%7530.12%
30 Sep, 180.21%616.05%
30 Jun, 180.19%930.18%
31 Mar, 180.14%887.09%
31 Dec, 170.13%1137.19%
30 Sep, 170.11%1629.48%
30 Jun, 170.08%1628.31%
31 Mar, 170.07%3168.37%
31 Dec, 160.05%2214.97%
30 Sep, 160.05%3580.78%
30 Jun, 160.04%1080.38%
31 Mar, 160.06%2823.01%
31 Dec, 150.05%12920.32%
30 Sep, 150.02%895.84%
30 Jun, 150.05%2415.63%
31 Mar, 150.04%3026.12%
31 Dec, 140.04%2594.76%
30 Sep, 140.04%2836.51%
30 Jun, 140.04%981.37%
31 Mar, 140.06%1300.29%
31 Dec, 130.07%1531.84%
30 Sep, 130.07%1594.44%
30 Jun, 130.06%7442.03%
31 Mar, 130.03%9522.73%
31 Dec, 120.02%19103.13%
30 Sep, 120.01%1667.92%
30 Jun, 120.02%5324.53%
31 Mar, 120.02%4589.30%
31 Dec, 110.02%164027.78%
30 Sep, 110.00%73722.73%
30 Jun, 110.00%1536.36%
31 Mar, 110.01%16725.88%
31 Dec, 100.01%70.27%
30 Sep, 100.11%797.87%
30 Jun, 100.12%-
31 Mar, 10--

As of 30 Jun 24, Takeda Pharmaceutical Company is held by 0.93% institutional shareholders, representing a 3.72% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2463-61.35%
31 Mar, 2416341.74%
31 Dec, 23115-21.23%
30 Sep, 231468.15%
30 Jun, 23135-12.34%
31 Mar, 2315419.38%
31 Dec, 22129-4.44%
30 Sep, 221357.14%
30 Jun, 22126-11.27%
31 Mar, 2214218.33%
31 Dec, 211202.56%
30 Sep, 21117-4.10%
30 Jun, 21122-23.27%
31 Mar, 2115924.22%
31 Dec, 201284.07%
30 Sep, 201232.50%
30 Jun, 201200.84%
31 Mar, 20119-20.67%
31 Dec, 1915017.19%
30 Sep, 19128-11.72%
30 Jun, 19145-60.60%
31 Mar, 19368332.94%
31 Dec, 1885844.44%
30 Sep, 18912.50%
30 Jun, 188100.00%
31 Mar, 184-
31 Dec, 17433.33%
30 Sep, 17350.00%
30 Jun, 172-66.67%
31 Mar, 176100.00%
31 Dec, 163-25.00%
30 Sep, 164300.00%
30 Jun, 161-83.33%
31 Mar, 166-
31 Dec, 15620.00%
30 Sep, 15525.00%
30 Jun, 154-20.00%
31 Mar, 15525.00%
31 Dec, 144-20.00%
30 Sep, 14566.67%
30 Jun, 143-25.00%
31 Mar, 144-42.86%
31 Dec, 13716.67%
30 Sep, 136-
30 Jun, 136200.00%
31 Mar, 132-33.33%
31 Dec, 123200.00%
30 Sep, 121-
30 Jun, 121-50.00%
31 Mar, 122100.00%
31 Dec, 111-
30 Sep, 111-
30 Jun, 11--100.00%
31 Mar, 113-
31 Dec, 10350.00%
30 Sep, 102-
30 Jun, 102100.00%
31 Mar, 101-

63 institutional shareholders have increased their position in TAK stock as of 30 Jun 24 compared to 163 in the previous quarter (a -61.35% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2452-36.59%
31 Mar, 2482-34.40%
31 Dec, 2312534.41%
30 Sep, 2393-2.11%
30 Jun, 239539.71%
31 Mar, 2368-30.61%
31 Dec, 229844.12%
30 Sep, 2268-21.84%
30 Jun, 228733.85%
31 Mar, 2265-38.10%
31 Dec, 2110520.69%
30 Sep, 2187-11.22%
30 Jun, 219836.11%
31 Mar, 2172-28.00%
31 Dec, 2010012.36%
30 Sep, 2089-8.25%
30 Jun, 2097-4.90%
31 Mar, 201025.15%
31 Dec, 1997-3.96%
30 Sep, 19101-12.17%
30 Jun, 19115858.33%
31 Mar, 191271.43%
31 Dec, 18775.00%
30 Sep, 18433.33%
30 Jun, 18350.00%
31 Mar, 182-50.00%
31 Dec, 174300.00%
30 Sep, 171-50.00%
30 Jun, 172-
31 Mar, 17--100.00%
31 Dec, 163200.00%
30 Sep, 161-75.00%
30 Jun, 164300.00%
31 Mar, 161-
31 Dec, 151-
30 Sep, 151-50.00%
30 Jun, 152100.00%
31 Mar, 151-66.67%
31 Dec, 14350.00%
30 Sep, 142-
30 Jun, 142-
31 Mar, 142-33.33%
31 Dec, 133200.00%
30 Sep, 131-
30 Jun, 131-
31 Mar, 131-
31 Dec, 12--
30 Sep, 12--100.00%
30 Jun, 121-
31 Mar, 121-
31 Dec, 111-
30 Sep, 11--100.00%
30 Jun, 111-
31 Mar, 11--100.00%
31 Dec, 101-
30 Sep, 101-
30 Jun, 10--
31 Mar, 10--

52 institutional shareholders have reduced their position in TAK stock as of 30 Jun 24 compared to 82 in the previous quarter (a -36.59% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24155-51.26%14,535,864-81.43%0.93%3.72%63-61.35%52-36.59%
31 Mar, 243182.91%78,260,425-6.36%4.99%17.58%16341.74%82-34.40%
31 Dec, 23309-1.59%83,572,6743.95%5.33%79.65%115-21.23%12534.41%
30 Sep, 23314-0.32%80,395,384-4.29%2.59%35.43%1468.15%93-2.11%
30 Jun, 233154.30%83,995,697-3.50%2.70%34.47%135-12.34%9539.71%
31 Mar, 233026.71%87,045,07127.85%2.80%58.38%15419.38%68-30.61%
31 Dec, 222832.91%68,081,5346.74%2.19%51.88%129-4.44%9844.12%
30 Sep, 222750.36%63,785,02412.04%2.05%62.12%1357.14%68-21.84%
30 Jun, 22274-3.86%56,930,7811.12%1.82%56.22%126-11.27%8733.85%
31 Mar, 22285-5.32%56,300,469-25.98%1.80%30.46%14218.33%65-38.10%
31 Dec, 213010.33%76,059,746-17.15%2.43%28.49%1202.56%10520.69%
30 Sep, 21300-3.54%91,800,960-2.97%2.92%31.97%117-4.10%87-11.22%
30 Jun, 21311-6.61%94,615,209-12.09%3.02%25.57%122-23.27%9836.11%
31 Mar, 213331.22%107,631,855-0.90%3.44%28.49%15924.22%72-28.00%
31 Dec, 203292.17%108,612,6081.13%3.47%29.44%1284.07%10012.36%
30 Sep, 20322-0.31%107,397,222-3.71%3.44%26.84%1232.50%89-8.25%
30 Jun, 203230.94%111,537,997-3.63%3.58%25.96%1200.84%97-4.90%
31 Mar, 20320-8.83%115,738,587-11.29%3.71%21.17%119-20.67%1025.15%
31 Dec, 193515.72%130,470,580-8.96%4.19%19.80%15017.19%97-3.96%
30 Sep, 19332-9.29%143,318,853-1.14%4.60%21.18%128-11.72%101-12.17%
30 Jun, 19366-10.51%144,969,670-18.86%4.66%14.13%145-60.60%115858.33%
31 Mar, 19409321.65%178,671,694230.85%5.74%48.47%368332.94%1271.43%
31 Dec, 1897506.25%54,003,8321751.04%3.44%7530.12%85844.44%775.00%
30 Sep, 181614.29%2,917,49217.24%0.21%616.05%912.50%433.33%
30 Jun, 181440.00%2,488,58431.62%0.19%930.18%8100.00%350.00%
31 Mar, 1810-1,890,67713.95%0.14%887.09%4-2-50.00%
31 Dec, 171025.00%1,659,16619.88%0.13%1137.19%433.33%4300.00%
30 Sep, 178-1,383,97933.08%0.11%1629.48%350.00%1-50.00%
30 Jun, 178-1,039,95814.32%0.08%1628.31%2-66.67%2-
31 Mar, 17814.29%909,69251.86%0.07%3168.37%6100.00%--100.00%
31 Dec, 16716.67%599,0322.09%0.05%2214.97%3-25.00%3200.00%
30 Sep, 166-14.29%586,79730.48%0.05%3580.78%4300.00%1-75.00%
30 Jun, 167-22.22%449,729-37.77%0.04%1080.38%1-83.33%4300.00%
31 Mar, 169-722,74629.70%0.06%2823.01%6-1-
31 Dec, 15912.50%557,239141.61%0.05%12920.32%620.00%1-
30 Sep, 15814.29%230,635-58.46%0.02%895.84%525.00%1-50.00%
30 Jun, 157-555,2695.08%0.05%2415.63%4-20.00%2100.00%
31 Mar, 157-528,42016.19%0.04%3026.12%525.00%1-66.67%
31 Dec, 147-454,782-0.89%0.04%2594.76%4-20.00%350.00%
30 Sep, 14716.67%458,8625.62%0.04%2836.51%566.67%2-
30 Jun, 146-25.00%434,429-40.07%0.04%981.37%3-25.00%2-
31 Mar, 148-33.33%724,954-9.12%0.06%1300.29%4-42.86%2-33.33%
31 Dec, 131233.33%797,6752.49%0.07%1531.84%716.67%3200.00%
30 Sep, 139-10.00%778,3085.21%0.07%1594.44%6-1-
30 Jun, 1310100.00%739,771119.55%0.06%7442.03%6200.00%1-
31 Mar, 13566.67%336,94770.40%0.03%9522.73%2-33.33%1-
31 Dec, 12350.00%197,73883.39%0.02%19103.13%3200.00%--
30 Sep, 122-33.33%107,822-59.04%0.01%1667.92%1---100.00%
30 Jun, 123-263,23412.89%0.02%5324.53%1-50.00%1-
31 Mar, 12350.00%233,1771.17%0.02%4589.30%2100.00%1-
31 Dec, 112100.00%230,471490.50%0.02%164027.78%1-1-
30 Sep, 111-39,03066.13%0.00%73722.73%1---100.00%
30 Jun, 111-75.00%23,493-81.41%0.00%1536.36%--100.00%1-
31 Mar, 114-20.00%126,36045.51%0.01%16725.88%3---100.00%
31 Dec, 10566.67%86,842-92.27%0.01%70.27%350.00%1-
30 Sep, 10350.00%1,123,645-4.17%0.11%797.87%2-1-
30 Jun, 102100.00%1,172,6001395852.38%0.12%-2100.00%--
31 Mar, 101-84---1---

Takeda Pharmaceutical Company Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 26, 2023TAKEDA PHARMACEUTICAL CO LTD-J-OtherSell1,000,000$40.08$40.08M-
Dec 01, 2022TAKEDA PHARMACEUTICAL CO LTDdirector-X-InTheMoneySell5,883,500---

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 26, 2023TAKEDA PHARMACEUTICAL CO LTD-J-OtherSell1,000,000$40.08$40.08M-
Dec 01, 2022TAKEDA PHARMACEUTICAL CO LTDdirector-X-InTheMoneyBuy5,883,500--6,724,000
Dec 01, 2022TAKEDA PHARMACEUTICAL CO LTDdirector-X-InTheMoneySell5,883,500---

The last insider sell of Takeda Pharmaceutical Company's stock was made by TAKEDA PHARMACEUTICAL CO LTD on May 26 2023, selling 1,000,000 shares at $40.08 per share (valued at $40.08M).

Takeda Pharmaceutical Company Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 202211100.00%

1 total buy trades, and 1 total sell trades (buy/sell ratio of 1.00%) were made by Takeda Pharmaceutical Company's insiders, as of Q4 2022.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 2022---

As of Q4 2022, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Takeda Pharmaceutical Company's stocks.

Takeda Pharmaceutical Company Peer Ownership


TickerCompany
EBSEmergent BioSolutions Inc.
ELANElanco Animal Health Incorporated
HLNHaleon plc
ESPREsperion Therapeutics, Inc.
VTRSViatris Inc.
PAHCPhibro Animal Health Corporation
NBIXNeurocrine Biosciences, Inc.
DCPHDeciphera Pharmaceuticals, Inc.
BHCBausch Health Companies Inc.
PBHPrestige Consumer Healthcare Inc.
TEVATeva Pharmaceutical Industries Limited
ZTSZoetis Inc.
PCRXPacira BioSciences, Inc.
COLLCollegium Pharmaceutical, Inc.
EVOEvotec SE
CTLTCatalent, Inc.
SIGASIGA Technologies, Inc.
EGRXEagle Pharmaceuticals, Inc.
AMPHAmphastar Pharmaceuticals, Inc.

TAK Ownership FAQ


Takeda Pharmaceutical Company is owned by institutional shareholders (0.93%), insiders (0.01%), and public (99.06%). The largest institutional shareholder of Takeda Pharmaceutical Company is CAPITAL RESEARCH GLOBAL INVESTORS (0.84% of total shares) and the top mutual fund owner is AMERICAN MUTUAL FUND (1.39% of total shares).

Takeda Pharmaceutical Company's major institutional shareholders are CAPITAL RESEARCH GLOBAL INVESTORS, MONDRIAN INVESTMENT PARTNERS LTD, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, and GOLDMAN SACHS GROUP INC. The top five shareholders own together 2.16% of the company's share outstanding.

As of Jun 2024, there are 155 institutional shareholders of Takeda Pharmaceutical Company.

CAPITAL RESEARCH GLOBAL INVESTORS owns 13.13M shares of Takeda Pharmaceutical Company, representing 0.84% of the company's total shares outstanding, valued at $169.86M (as of Jun 2024).

As of Jun 2024, MONDRIAN INVESTMENT PARTNERS LTD holds 7.74M shares of Takeda Pharmaceutical Company (TAK), compromising 0.49% of the company, valued at $108.34M.

MORGAN STANLEY is the third largest holder of Takeda Pharmaceutical Company. The company owns 4.99M of the company's shares outstanding (worth $64.53M).